ACME's DiaCare has collaborated with the esteemed endocrinologists of Bangladesh for the benefits of Diabetic population of Bangladesh with the novel solution Imegli (Imeglimin). President of Bangladesh Endocrine Society (BES) Prof. Hafijur Rahman Sir, General Secretary of BES Associate Prof. Shahjada Selim Sir, Associate Prof. M Saifuddin Sir along with other endocrinologists and Managing Director along with other top management of The ACME Laboratories Ltd. were present on this clinical trial kickoff meeting.
- Home
- About Us
- Products
- Facilities
- CSR
- Business Operations
-
Investors Corner
- Corporate Brief
- Director's Report
- Financial Reports
- Price Sensitive Information
- Material Information
- Unclaimed Dividend Information
- Shareholding Position
- Declaration
- C G Compliance Status
- Code of Conduct
- The Principles of Disclosure of MI & PSI
- Dividend Distribution Policy
- Annual General Meeting
- Use of IPO Proceeds
- Share Information
- Investor Relations Contact
- Doctors Corner
- Career
- Newsroom/Media
- Climate & Environment
- Contact Us